viernes, 1 de junio de 2018

NPH: Reversing Brain Disorder? - Ivanhoe Broadcast News, Inc.

NPH: Reversing Brain Disorder? - Ivanhoe Broadcast News, Inc.

Marketing


ST. LOUIS, Mo. (Ivanhoe Newswire) — Chronic itch affects up to 15 percent of the population and for many patients, it can be a life-changing condition because the urge to itch is always there, disrupting everyday activities and making it nearly impossible to sleep well. Now, for the first time, doctors have found a drug that could finally offer relief.




ORLANDO, Fla. (Ivanhoe Newswire) — Imagine you or a loved one are walking normally, then slowly you start to shuffle.  You lose bladder control, and possibly most frightening, your memory starts to fade. These are all symptoms that point toward Parkinson’s or Alzheimer’s. There is one little known condition that mimics these diseases, but NPH patients can get better.




TAMPA, Fla. (Ivanhoe Newswire) — We’ve all heard how the glass ceiling in business keeps women from making it to the top, and that’s especially true for African American women. But the executive you’re about to meet has electrified her field and is making waves.




MIAMI, Fla. (Ivanhoe Newswire) — Fibromyalgia is often called a mystery illness that causes debilitating pain and fatigue. Most patients take pills to help relieve symptoms. Now, new technology is offering help without the side effects of medication.




SAN DIEGO, Calif. (Ivanhoe Newswire) — The CDC estimates that one in 68 children in the U.S. are on the autism spectrum. Right now, there are no FDA approved treatments for the disorder or its symptoms, which can include difficulty with social skills, communication and repetitive behavior. 










Doctor's In-depth Interview of the week
 
Code Sepsis: A Miracle Walks In the Door


 





Quote of the week:

The only thing that could spoil a day was people. People were always the limiters of happiness except for the very few that were as good as spring itself.” 

— 
Ernest Hemingway





 






Website Information:webdoctor@ivanhoe.com

Content Licensing: jcherry@ivanhoe.com

No hay comentarios:

Publicar un comentario